The power of reversibility regulating gene activities via tetracycline-controlled transcription.

Tetracycline-controlled transcriptional activation systems are widely used to control gene expression in transgenic animals in a truly conditional manner. By this we refer to the capability of these expression systems to control gene activities not only in a tissue specific and temporal defined but also reversible manner. This versatility has made the Tet regulatory systems to a preeminent tool in reverse mouse genetics. The development of the technology in the past 15 years will be reviewed and guidelines will be given for its implementation in creating transgenic rodents. Finally, we highlight some recent exciting applications of the Tet technology as well as its foreseeable combination with other emerging technologies in mouse transgenesis.

[1]  E. Kandel,et al.  mGluR2 acts through inhibitory Galpha subunits to regulate transmission and long-term plasticity at hippocampal mossy fiber-CA3 synapses. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[2]  T. Quertermous,et al.  Inducible and selective transgene expression in murine vascular endothelium. , 2002, Physiological genomics.

[3]  C. Klein,et al.  The Metastasis Cascade , 2008, Science.

[4]  Kenneth Chang,et al.  Lessons from Nature: microRNA-based shRNA libraries , 2006, Nature Methods.

[5]  M. López de Armentia,et al.  Enhanced CREB-dependent gene expression increases the excitability of neurons in the basal amygdala and primes the consolidation of contextual and cued fear memory. , 2009, Learning & memory.

[6]  Wolfgang Hillen,et al.  Gene regulation by tetracyclines. , 2004, Genetic engineering.

[7]  Bernd J. Pichler,et al.  Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease , 2008, The Journal of Neuroscience.

[8]  Priti Kumar,et al.  Conditional RNAi: towards a silent gene therapy. , 2009, Advanced drug delivery reviews.

[9]  I. Goshen,et al.  VEGF is required for dendritogenesis of newly born olfactory bulb interneurons , 2010, Development.

[10]  S. Efrat,et al.  Conditional transformation of a pancreatic beta-cell line derived from transgenic mice expressing a tetracycline-regulated oncogene. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Patrick Aebischer,et al.  A versatile tool for conditional gene expression and knockdown , 2006 .

[12]  R. Weinberg.  Leaving home early: reexamination of the canonical models of tumor progression. , 2008, Cancer cell.

[13]  M. D. Barton,et al.  Modified GFAP promoter auto-regulates tet-activator expression for increased transactivation and reduced tTA-associated toxicity. , 2002, Brain research. Molecular brain research.

[14]  L. Muglia,et al.  Requirement for p38 Mitogen-Activated Protein Kinase Activity in Neointima Formation After Vascular Injury , 2008, Circulation.

[15]  Wei Wang,et al.  piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells , 2009, Nature.

[16]  H. Jäck,et al.  Induction of pre-B cell proliferation after de novo synthesis of the pre-B cell receptor. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[17]  H. Bujard,et al.  The Potential for β-Structure in the Repeat Domain of Tau Protein Determines Aggregation, Synaptic Decay, Neuronal Loss, and Coassembly with Endogenous Tau in Inducible Mouse Models of Tauopathy , 2008, The Journal of Neuroscience.

[18]  René Hen,et al.  Reversal of Neuropathology and Motor Dysfunction in a Conditional Model of Huntington's Disease , 2000, Cell.

[19]  M. Gossen.  Conditional gene expression: Intelligent designs , 2006, Gene Therapy.

[20]  R. Sarao,et al.  Conditional Transgene Expression in Endothelial Cells , 1998, Transgenic Research.

[21]  A. Das,et al.  Viral Evolution as a Tool to Improve the Tetracycline-regulated Gene Expression System* , 2004, Journal of Biological Chemistry.

[22]  L. Chin,et al.  Essential role for oncogenic Ras in tumour maintenance , 1999, Nature.

[23]  J. Tichelaar,et al.  Conditional Expression of Fibroblast Growth Factor-7 in the Developing and Mature Lung* , 2000, The Journal of Biological Chemistry.

[24]  Yadin Dudai,et al.  Memory from A to Z: Keywords, Concepts, and Beyond , 2002 .

[25]  A. F. Stewart,et al.  A practical summary of site-specific recombination, conditional mutagenesis, and tamoxifen induction of CreERT2. , 2010, Methods in enzymology.

[26]  Jianqiang Ding,et al.  Divergent roles of endothelial NF-κB in multiple organ injury and bacterial clearance in mouse models of sepsis , 2008, The Journal of experimental medicine.

[27]  R. Burke,et al.  Regulation of the Development of Mesencephalic Dopaminergic Systems by the Selective Expression of Glial Cell Line-Derived Neurotrophic Factor in Their Targets , 2004, The Journal of Neuroscience.

[28]  Alison Abbott,et al.  Laboratory animals: The Renaissance rat , 2004, Nature.

[29]  G. Fishman,et al.  Regulated expression of foreign genes in vivo after germline transfer. , 1994, The Journal of clinical investigation.

[30]  S. Lira,et al.  Transient lung-specific expression of the chemokine KC improves outcome in invasive aspergillosis. , 2002, American journal of respiratory and critical care medicine.

[31]  J. Habener,et al.  Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1. , 2001, The Journal of clinical investigation.

[32]  Rudolf Jaenisch,et al.  Single-gene transgenic mouse strains for reprogramming adult somatic cells , 2010, Nature Methods.

[33]  M. Husain,et al.  Conditional and targeted overexpression of vascular chymase causes hypertension in transgenic mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  K. Ashe,et al.  Age-Dependent Neurofibrillary Tangle Formation, Neuron Loss, and Memory Impairment in a Mouse Model of Human Tauopathy (P301L) , 2005, The Journal of Neuroscience.

[35]  D. Felsher,et al.  Reversible tumorigenesis by MYC in hematopoietic lineages. , 1999, Molecular cell.

[36]  Bert Sakmann,et al.  Conditional Restoration of Hippocampal Synaptic Potentiation in GluR-A-Deficient Mice , 2001, Science.

[37]  D. Felsher.  Reversing cancer from inside and out: oncogene addiction, cellular senescence, and the angiogenic switch. , 2008, Lymphatic research and biology.

[38]  E. Kuipers,et al.  Generation of a tightly regulated doxycycline‐inducible model for studying mouse intestinal biology , 2009, Genesis.

[39]  Susumu Tonegawa,et al.  Transgenic Inhibition of Synaptic Transmission Reveals Role of CA3 Output in Hippocampal Learning , 2008, Science.

[40]  A. Israël,et al.  Forebrain-Specific Neuronal Inhibition of Nuclear Factor-κB Activity Leads to Loss of Neuroprotection , 2003, The Journal of Neuroscience.

[41]  Eric R. Kandel,et al.  Expression of Constitutively Active CREB Protein Facilitates the Late Phase of Long-Term Potentiation by Enhancing Synaptic Capture , 2002, Cell.

[42]  L. Tsui,et al.  Regulated expression of the human CFTR gene in epithelial cells. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[43]  A. Mills,et al.  Getting around lethality with inducible Cre-mediated excision. , 2002, Seminars in cell & developmental biology.

[44]  E. Whitelaw,et al.  The vagaries of variegating transgenes. , 1996, BioEssays : news and reviews in molecular, cellular and developmental biology.

[45]  Michael Bader,et al.  Inducible Transgenic Rat Model for Diabetes Mellitus Based on shRNA-Mediated Gene Knockdown , 2009, PloS one.

[46]  M. Gossen,et al.  Co-regulation of two gene activities by tetracycline via a bidirectional promoter. , 1995, Nucleic acids research.

[47]  M. Gossen,et al.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Axel,et al.  Genetic Ablation and Restoration of the Olfactory Topographic Map , 2000, Cell.

[49]  A. Paterson,et al.  Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFα expression in transgenic mice , 1999, Oncogene.

[50]  Austin G Smith,et al.  Capture of Authentic Embryonic Stem Cells from Rat Blastocysts , 2008, Cell.

[51]  C. Lengner,et al.  Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. , 2008, Cell stem cell.

[52]  F. Jaisser,et al.  Targeted transgenesis at the HPRT locus: an efficient strategy to achieve tightly controlled in vivo conditional expression with the tet system. , 2009, Physiological genomics.

[53]  M. T. Hasan,et al.  Select Overexpression of Homer1a in Dorsal Hippocampus Impairs Spatial Working Memory , 2007, Front. Neurosci..

[54]  E. Kandel,et al.  Control of Memory Formation Through Regulated Expression of a CaMKII Transgene , 1996, Science.

[55]  Kevin Eggan,et al.  Progress toward the clinical application of patient-specific pluripotent stem cells. , 2010, The Journal of clinical investigation.

[56]  H. Reichardt,et al.  Inducible and reversible gene silencing by stable integration of an shRNA-encoding lentivirus in transgenic rats , 2008, Proceedings of the National Academy of Sciences.

[57]  Ted Abel,et al.  Genetic Disruption of Protein Kinase A Anchoring Reveals a Role for Compartmentalized Kinase Signaling in Theta-Burst Long-Term Potentiation and Spatial Memory , 2007, The Journal of Neuroscience.

[58]  Hermann Bujard,et al.  Generating conditional mouse mutants via tetracycline-controlled gene expression. , 2003, Methods in molecular biology.

[59]  Dirk Görlich,et al.  Inducible expression of coding and inhibitory RNAs from retargetable genomic loci , 2009, Nucleic acids research.

[60]  R. Biamonte,et al.  Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study , 2006, BMC Cancer.

[61]  Rudolf Jaenisch,et al.  Efficient method to generate single‐copy transgenic mice by site‐specific integration in embryonic stem cells , 2006, Genesis.

[62]  V. D’Agati,et al.  The role of GDNF in patterning the excretory system. , 2005, Developmental biology.

[63]  M. Gossen,et al.  Use of tetracycline-controlled gene expression systems to study mammalian cell cycle. , 1997, Methods in enzymology.

[64]  Rudolf Jaenisch,et al.  Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells , 2009, Nature Biotechnology.

[65]  Wendy W. Wu,et al.  Transgenic silencing of neurons in the mammalian brain by expression of the allatostatin receptor (AlstR). , 2009, Journal of neurophysiology.

[66]  T. Chu,et al.  RESEARCH ARTICLE Open Access Generation and characterization of a Tet-On (rtTA-M2) transgenic rat , 2022 .

[67]  G. Fishman,et al.  Conditional lineage ablation to model human diseases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[68]  C. Hsieh,et al.  Germline Competent Embryonic Stem Cells Derived from Rat Blastocysts , 2008, Cell.

[69]  J. S. Gutkind,et al.  Conditional Expression of K-ras in an Epithelial Compartment that Includes the Stem Cells Is Sufficient to Promote Squamous Cell Carcinogenesis , 2004, Cancer Research.

[70]  C. Lengner,et al.  Transgenic Mice with Defined Combinations of Drug Inducible Reprogramming Factors , 2008, Nature Biotechnology.

[71]  Eric R Kandel,et al.  Restricted and Regulated Overexpression Reveals Calcineurin as a Key Component in the Transition from Short-Term to Long-Term Memory , 1998, Cell.

[72]  D. Largaespada,et al.  Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse. , 2005, Blood.

[73]  R. Tuder,et al.  Pulmonary Hypertension in Transgenic Mice Expressing a Dominant-Negative BMPRII Gene in Smooth Muscle , 2004, Circulation research.

[74]  F. Costantini,et al.  Development of a unique system for spatiotemporal and lineage-specific gene expression in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[75]  A. P. Soler,et al.  Conversion of C57Bl/6 mice from a tumor promotion–resistant to a –sensitive phenotype by enhanced ornithine decarboxylase expression , 1999, Molecular carcinogenesis.

[76]  S. Lowe,et al.  Tissue-specific and reversible RNA interference in transgenic mice , 2007, Nature Genetics.

[77]  Aubin Michalon,et al.  Inducible and neuron‐specific gene expression in the adult mouse brain with the rtTA2S‐M2 system , 2005, Genesis.

[78]  B. Engelhardt,et al.  E- and P-Selectin Are Not Required for the Development of Experimental Autoimmune Encephalomyelitis in C57BL/6 and SJL Mice1 , 2007, The Journal of Immunology.

[79]  A. Das,et al.  Optimization of the Tet-On system for regulated gene expression through viral evolution , 2006, Gene Therapy.

[80]  F. Costantini,et al.  Impaired neural development caused by inducible expression of Axin in transgenic mice , 2007, Mechanisms of Development.

[81]  M. T. Hasan,et al.  Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[82]  C. Benoist,et al.  Role of the forkhead transcription family member, FKHR, in thymocyte differentiation , 2000, European journal of immunology.

[83]  M. Schwab,et al.  Nogo-A expressed in Schwann cells impairs axonal regeneration after peripheral nerve injury , 2002, The Journal of cell biology.

[84]  Hermann Bujard,et al.  Control of gene activity in higher eukaryotic cells by prokaryotic regulatory elements , 1993 .

[85]  M. Kelz,et al.  Transgenic animals with inducible, targeted gene expression in brain. , 1998, Molecular pharmacology.

[86]  Maureen P. Boyle,et al.  Transient Early-Life Forebrain Corticotropin-Releasing Hormone Elevation Causes Long-Lasting Anxiogenic and Despair-Like Changes in Mice , 2010, The Journal of Neuroscience.

[87]  M. Mayford,et al.  Transgenic Calmodulin-Dependent Protein Kinase II Activation: Dose-Dependent Effects on Synaptic Plasticity, Learning, and Memory , 2002, Journal of Neuroscience.

[88]  C. Landel,et al.  Developing tTA Transgenic Rats for Inducible and Reversible Gene Expression , 2009, International journal of biological sciences.

[89]  Jinhyung Kim,et al.  A Genetic Switch for Epilepsy in Adult Mice , 2004, The Journal of Neuroscience.

[90]  M. Gossen,et al.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[91]  A. Glick,et al.  Conditional gene expression in the epidermis of transgenic mice using the tetracycline-regulated transactivators tTA and rTA linked to the keratin 5 promoter. , 2000, The Journal of investigative dermatology.

[92]  Hermann Bujard,et al.  Studying gene function in eukaryotes by conditional gene inactivation. , 2002, Annual review of genetics.

[93]  U. Deuschle,et al.  Tetracycline-reversible silencing of eukaryotic promoters , 1995, Molecular and cellular biology.

[94]  Harold Varmus,et al.  Seeding and Propagation of Untransformed Mouse Mammary Cells in the Lung , 2008, Science.

[95]  Hongkui Zeng,et al.  An Inducible and Reversible Mouse Genetic Rescue System , 2008, PLoS genetics.

[96]  Chia-Yang Liu,et al.  Characterization of tetracycline-inducible bitransgenic Krt12rtTA/+/tet-O-LacZ mice. , 2005, Investigative ophthalmology & visual science.

[97]  E. Kandel,et al.  Inducible and Reversible Gene Expression with the rtTA System for the Study of Memory , 1998, Neuron.

[98]  K. Ashe,et al.  Amyloid plaque and neurofibrillary tangle pathology in a regulatable mouse model of Alzheimer's disease. , 2008, The American journal of pathology.

[99]  C. Capen,et al.  Creation and characterization of a doxycycline-inducible mouse model of thyroid-targeted RET/PTC1 oncogene and luciferase reporter gene coexpression. , 2007, Thyroid : official journal of the American Thyroid Association.

[100]  J. Utikal,et al.  Induced Pluripotent Stem Cells Generated Without Viral Integration , 2008, Science.

[101]  J. Wysolmerski,et al.  Temporally regulated overexpression of parathyroid hormone-related protein in the mammary gland reveals distinct fetal and pubertal phenotypes. , 2001, The Journal of endocrinology.

[102]  Hyoung-Gon Lee,et al.  Growth Factors , Cytokines , Cell Cycle Molecules The Neuronal Expression of MYC Causes a Neurodegenerative Phenotype in a Novel Transgenic Mouse , 2010 .

[103]  B. Hyman,et al.  Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function , 2005, Science.

[104]  P. Greengard,et al.  Forebrain overexpression of CK1δ leads to down-regulation of dopamine receptors and altered locomotor activity reminiscent of ADHD , 2010, Proceedings of the National Academy of Sciences.

[105]  Juan I. Young,et al.  Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis. , 2007, Human molecular genetics.

[106]  B. Engelhardt,et al.  Inducible endothelial cell-specific gene expression in transgenic mouse embryos and adult mice. , 2008, Experimental cell research.

[107]  Robert B Boxer,et al.  A novel doxycycline‐inducible system for the transgenic analysis of mammary gland biology , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[108]  Marius Wernig,et al.  A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types , 2008, Nature Biotechnology.

[109]  Ignacio Anegon,et al.  Knockout Rats via Embryo Microinjection of Zinc-Finger Nucleases , 2009, Science.

[110]  B. Göttgens,et al.  Inducible chronic phase of myeloid leukemia with expansion of hematopoietic stem cells in a transgenic model of BCR-ABL leukemogenesis. , 2005, Blood.

[111]  E. Shimizu,et al.  NMDA receptor-dependent synaptic reinforcement as a crucial process for memory consolidation. , 2000, Science.

[112]  K. Akashi,et al.  Transgenic targeting with regulatory elements of the human CD34 gene. , 2002, Blood.

[113]  K. Rajewsky,et al.  Stringent doxycycline dependent control of CRE recombinase in vivo. , 2002, Nucleic acids research.

[114]  M. Gossen,et al.  Transcriptional activation by tetracyclines in mammalian cells. , 1995, Science.

[115]  René Hen,et al.  Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult , 2002, Nature.

[116]  J. McDonald,et al.  Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart , 2001, Transgenic Research.

[117]  Hermann Bujard,et al.  The β-Propensity of Tau Determines Aggregation and Synaptic Loss in Inducible Mouse Models of Tauopathy* , 2007, Journal of Biological Chemistry.

[118]  L. Montoliu,et al.  A transgenic mouse model with inducible Tyrosinase gene expression using the tetracycline (Tet-on) system allows regulated rescue of abnormal chiasmatic projections found in albinism. , 2004, Pigment cell research.

[119]  L. Kaczmarek,et al.  Tet system in the brain: Transgenic rats and lentiviral vectors approach , 2009, Genesis.

[120]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[121]  D. Otteson,et al.  A system for inducible gene expression in retinal ganglion cells. , 2005, Investigative ophthalmology & visual science.